跳至主要内容
临床试验/NL-OMON53446
NL-OMON53446
招募中
不适用

Genetic Risk factors for Multi-system Inflammatory Syndrome in Children and Pediatric Post COVID condition (GRIP) - GRIP

eids Universitair Medisch Centrum0 个研究点目标入组 400 人待定

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
未指定
发起方
eids Universitair Medisch Centrum
入组人数
400
状态
招募中
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
2年前
研究类型
Observational non invasive

研究者

入排标准

入选标准

  • 1\. Children with a history of MIS\-C: as defined according to WHO criteria \[36],
  • who were 0\-18 at the time of MIS\-C
  • 2\. Children with post\-COVID condition who were 0\-18 at the time of SARS\-CoV\-2
  • infection: as defined according to the WHO case definition \[37].
  • This includes a history of probable or confirmed prior SARS\-CoV\-2 infection,
  • with signs and symptoms (including fatigue, shortness of breath, cognitive
  • dysfunction) that are present after 12 weeks, last at least 2 months, have an
  • impact on daily functioning and are not explained by an alternative diagnosis.
  • Post\-COVID condition must be diagnosed by a pediatrician.
  • 3\. \*Exposed\* control group: children with a history of proven SARS\-CoV\-2

排除标准

  • 1\. Group 1 (MIS\-C): no specific exclusion criteria
  • 2\. Group 2 (post\-COVID condition): other plausible cause of symptoms AND/OR a
  • history compatible with chronic fatigue syndrome prior to infection with
  • SARS\-CoV\-2\. Children with a history of MIS\-C who suffer prolonged signs and
  • symptoms will be included in the MIS\-C group. Patients who were not diagnosed
  • with Post\-COVID condition by a pediatrician, but only by for example a general
  • practitioner, are excluded.
  • 3\. Group 3 (\*exposed\* control group): MIS\-C or post\-COVID condition; AND/OR
  • Moderate or severe course of COVID\-19, defined as: need for supplemental oxygen
  • and/or intensive care admission because of COVID\-19 and/or death. Children are

结局指标

主要结局

未指定

相似试验